Project Grant R01DA064125
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Louisiana, USA
Similar Awards
- This Project Grant award of $761,367, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine whether biomarkers in fetal central nervous system-derived extracellular vesicles can predict derangements in fetal neurodevelopment in women using cannabinoids during pregnancy. The 5-year project, which began on September 1, 2025, will partner with an ongoing NIH-funded clinical cohort of 450 subjects to identify novel...
- This Project Grant award, titled "LONGITUDINAL EFFECTS OF PRENATAL CANNABIS AND TOBACCO CO-EXPOSURE AND POSTNATAL ADVERSITY ON CHILD REGULATION: THE BUFFERING ROLE OF SENSITIVE PARENTING," is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under CFDA Program 93.279 - Drug Use and Addiction Research Programs. The $149,000 grant will be awarded to the University of Oregon to conduct a secondary analysis of a longitudinal study...
- This $616,372 federal Project Grant was awarded on July 15, 2025 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to identify neuronal, glial, and neural stem/progenitor cell transposable element (TE) transcriptional and epigenetic gene regulatory states involved in SIV, antiretroviral therapy, and cannabinoid exposure in a non-human primate model. Additionally, the research aims to identify TE expression...
- This federal Project Grant award of $196,236.00, provided by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs), aims to investigate the mechanisms contributing to preconceptions about those who use cannabis, especially during pregnancy, and the impact on the quality of prenatal care. The key objectives of the 5-year project (July 2025 - June 2030) are to: (1) investigate preconceptions about cannabis use during pregnancy using a mixed-methods approach...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has awarded a $718,374 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Nebraska Medical Center (UNMC). The 5-year grant, effective September 1, 2025, will support research to uncover how the co-exposure of nicotine exacerbates the adverse effects of antiretroviral drugs on placental development in pregnant women living with HIV-1. The study aims to employ...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $426,036 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tulane University. The award will fund a study to examine the feasibility and acceptability of a virtual reality-based mindfulness intervention, called "TRIPP," to support people with comorbid HIV and substance use disorders. This population faces significant public health challenges, as substance...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study on the prevalence and characteristics of cannabidiol (CBD) use during pregnancy. The study aims to: 1) Estimate the prevalence of CBD use overall and by trimester in a clinical sample of 800 pregnant women receiving prenatal care at the University of Colorado; 2) Characterize women who use CBD and/or cannabis during pregnancy in terms...
- This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
- The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...
- This $507,000.00 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at the Icahn School of Medicine at Mount Sinai to investigate the epigenetic mechanisms underlying cannabis use disorder. The project, running from September 1, 2025 to May 31, 2030, aims to leverage a translational animal model of voluntary THC consumption to study sex differences and individual variability in...